Inventor
ZHU ZHAONING
GB73 patents
⚠️ This page may combine multiple inventors who share the name “ZHU ZHAONING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
16 patentsUS6911428B2Jun 28, 2005
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP124 citations98
US7763609B2Jul 27, 2010
Heterocyclic aspartyl protease inhibitors
SCHERING CORP38 citations95
US7592348B2Sep 22, 2009
Heterocyclic aspartyl protease inhibitors
SCHERING CORP16 citations92
US6458812B1Oct 1, 2002
Muscarinic antagonists
SCHERING CORP56 citations91
US7868000B2Jan 11, 2011
Aspartyl protease inhibitors
SCHERING CORP18 citations84
US7700603B2Apr 20, 2010
Heterocyclic aspartyl protease inhibitors
SCHERING CORP9 citations84
US8012960B2Sep 6, 2011
Heterocyclic aspartyl protease inhibitors
SCHERING CORP5 citations74
US7763606B2Jul 27, 2010
Heterocyclic aspartyl protease inhibitors
SCHERING CORP5 citations74
US7973067B2Jul 5, 2011
Heterocyclic aspartyl protease inhibitors
SCHERING CORP6 citations73
US6838466B2Jan 4, 2005
Compounds for the treatment of inflammatory disorders
SCHERING CORP10 citations72
US7812013B2Oct 12, 2010
Macrocyclic heterocyclic aspartyl protease inhibitors
SCHERING CORP5 citations63
US7759353B2Jul 20, 2010
Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatment
SCHERING CORP5 citations63
US7759354B2Jul 20, 2010
Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof
SCHERING CORP5 citations63
US7560451B2Jul 14, 2009
Aspartyl protease inhibitors
SCHERING CORP5 citations63
US7652020B2Jan 26, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP5 citations62
US7459450B2Dec 2, 2008
Neuropeptide receptor modulators
SCHERING CORP5 citations60
ZHU ZHAONING
9 patentsUS8183252B2May 22, 2012
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING8 citations84
US8691831B2Apr 8, 2014
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING7 citations83
US8450331B2May 28, 2013
Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
ZHU ZHAONING5 citations83
US8829036B2Sep 9, 2014
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING7 citations82
US8691833B2Apr 8, 2014
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING7 citations82
US8426403B2Apr 23, 2013
Gamma secretase modulators
ZHU ZHAONING2 citations62
US8242112B2Aug 14, 2012
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING2 citations62
US8178513B2May 15, 2012
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING1 citations62
US8673900B2Mar 18, 2014
Gamma secretase modulators
ZHU ZHAONING2 citations59
UCB BIOPHARMA SPRL
9 patentsUS10087179B2Oct 2, 2018
Fused tricyclic imidazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL8 citations81
US9932343B2Apr 3, 2018
Fused tricyclic benzimidazoles derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL10 citations81
US9890174B2Feb 13, 2018
Fused Tricyclic imidazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL8 citations81
US9550737B2Jan 24, 2017
TNF -α modulating benzimidazoles
UCB BIOPHARMA SPRL4 citations71
US10202405B2Feb 12, 2019
Fused pentacyclic imidazole derivatives
UCB BIOPHARMA SPRL4 citations70
US9475820B2Oct 25, 2016
Substituted imidazo[1,2-a]pyrazines as TNF activity modulators
UCB BIOPHARMA SPRL3 citations70
US9815797B2Nov 14, 2017
Fused bicyclic heteroaromatic derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL2 citations69
US9309243B2Apr 12, 2016
Imidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL4 citations68
US10464932B2Nov 5, 2019
Iminothiadiazinane dioxide derivatives as plasmepsin V inhibitors
UCB BIOPHARMA SPRL1 citations61
UCB Biopharma SRL
4 patentsUS10906919B2Feb 2, 2021
Fused pentacyclic imidazole derivatives
UCB Biopharma SRL2 citations70
US11912721B2Feb 27, 2024
Fused pentacyclic imidazole derivatives
UCB Biopharma SRL0 citations60
US10980814B2Apr 20, 2021
Fused pentacyclic imidazole derivatives as modulators of TNF activity
UCB Biopharma SRL0 citations60
US11479546B2Oct 25, 2022
Antimalarial hexahydropyrimidine analogues
UCB Biopharma SRL0 citations58
DENDREON CORP
3 patentsUS7012066B2Mar 14, 2006
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP176 citations98
US7244721B2Jul 17, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP80 citations97
US7169760B2Jan 30, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP88 citations97
SAKSENA ANIL K
1 patentHUANG XIANHAI
1 patentASBEROM THEODROS
1 patentISERLOH ULRICH
1 patentGREENLEE WILLIAM
1 patentSTAMFORD ANDREW W
1 patentGREENLEE WILLIAM J
1 patentWU YUSHENG
1 patentSTAMFORD ANDREW
1 patentShowing the top 50 of 73 patents by PatentIndex Score.